未登录 分享 收藏
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase 慢性髓性白血病慢性期治疗不耐受的专家共识定义 Atallah, Ehab; Broder, Michael S.; Chan, Onyee; Flynn, Kathryn E.; Gilreath, Jeffrey A.; Hine, Marisa; Hunter, Anthony M.; Mattson, Hannah T. D.; Mauro, Michael J.; Pinilla-Ibarz, Javier; Rein, Lindsay A. M.; Stemper, Evan; Tantravahi, Srinivas; Yang, Jay; Shah, Neil P. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress ONC213：一种通过诱导线粒体应激使耐药AML细胞重敏于venetoclax的新型策略 Carter, Jenna L.; Su, Yongwei; Al-Antary, Eman T.; Zhao, Jianlei; Qiao, Xinan; Wang, Guan; Edwards, Holly; Polin, Lisa; Kushner, Juiwanna; Dzinic, Sijana H.; White, Kathryn; Buck, Steven A.; Huettemann, Maik; Allen, Joshua E.; Prabhu, Varun V.; Yang, Jay; Taub, Jeffrey W.; Ge, Yubin 分享 收藏
US Expert Consensus on Defining Intolerance to Tyrosine Kinase Inhibitor Treatment in Chronic Phase Chronic Myeloid Leukemia (CML) 美国专家共识：慢性期慢性粒细胞白血病(CML)对酪氨酸激酶抑制剂治疗的耐受不良定义 Atallah, Ehab L.; Broder, Michael S.; Chan, Onyee; Dalglish, Hannah; Flynn, Kathryn E.; Gilreath, Jeffrey; Hine, Marisa; Hunter, Anthony M.; Mauro, Michael J.; Pinilla-Ibarz, Javier; Rein, Lindsay A. M.; Shah, Neil P.; Stemper, Evan; Tantravahi, Srinivas K.; Yang, Jay 分享 收藏
A Phase I Dose Escalation and Expansion Trial of Lyt-200 (a First-In-Class Anti-Galectin-9 Antibody) Alone and in Combination with Venetoclax/HMA in AML/MDS 一项Lyt-200（一种首创抗Galectin-9抗体）单药及联合Venetoclax/HMA在AML/MDS中的剂量递增与扩展I期临床试验 Fathi, Amir T.; Filipovic, Aleksandra; Maher, Keri; Schaar, Dale G.; Niroula, Rabin; Maly, Joseph J.; Jaykumar, Deepa; Merin, Noah; Yang, Jay; Silva, Jorge R. Galvez; Gang, Varun; Meeks, Taylor; Korth, Christopher; Koehne, Guenther 分享 收藏
Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia Ziftomenib与Selinexor的联合使用对NPM1突变急性髓系白血病有效 Dhiman, Sandhya; Uddin, Md. Hafiz; Dhillon, Vikram; Aguilar, Jeff Justin; Aboukameel, Amro; Khan, Husain; Bannoura, Sahar; Yang, Jay; Dyson, Gregory; Buck, Steven; Azmi, Asfar; Polin, Lisa; Burrows, Francis; Kessler, Linda; Maciejewski, Jaroslaw; Balasubramanian, Suresh Kumar 分享 收藏
分享 收藏
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro Hurrish, Katie H.; Su, Yongwei; Patel, Shraddha; Ramage, Cassandra L.; Zhao, Jianlei; Temby, Brianna R.; Carter, Jenna L.; Edwards, Holly; Buck, Steven A.; Wiley, Sandra E.; Huttemann, Maik; Polin, Lisa; Kushner, Juiwanna; Dzinic, Sijana H.; White, Kathryn; Bao, Xun; Li, Jing; Yang, Jay; Boerner, Julie; Hou, Zhanjun; Al-Atrash, Gheath; Konoplev, Sergej N.; Busquets, Jonathan; Tiziani, Stefano; Matherly, Larry H.; Taub, Jeffrey W.; Konopleva, Marina; Ge, Yubin; Baran, Natalia 分享 收藏
Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms Carter, Jenna L.; Su, Yongwei; Qiao, Xinan; Zhao, Jianlei; Wang, Guan; Howard, Mackenzie; Edwards, Holly; Bao, Xun; Li, Jing; Huettemann, Maik; Yang, Jay; Taub, Jeffrey W.; Ge, Yubin 分享 收藏
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML Olutasidenib (FT-2102) 可诱导复发或难治性IDH1-mutated AML患者持久完全缓解 de Botton, Stephane; Fenaux, Pierre; Yee, Karen; Recher, Christian; Wei, Andrew H.; Montesinos, Pau; Taussig, David C.; Pigneux, Arnaud; Braun, Thorsten; Curti, Antonio; Grove, Carolyn; Jonas, Brian A.; Khwaja, Asim; Legrand, Ollivier; Peterlin, Pierre; Arnan, Montserrat; Blum, William; Cilloni, Daniela; Hiwase, Devendra K.; Jurcic, Joseph G.; Krauter, Juergen; Thomas, Xavier; Watts, Justin M.; Yang, Jay; Polyanskaya, Olga; Brevard, Julie; Sweeney, Jennifer; Barrett, Emma; Cortes, Jorge 分享 收藏
分享 收藏
FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP Fu, Zhongjie; Lundgren, Pia; Pivodic, Aldina; Yagi, Hitomi; Harman, Jarrod C.; Yang, Jay; Ko, Minji; Neilsen, Katherine; Talukdar, Saswata; Hellstrom, Ann; Smith, Lois E. H. 分享 收藏
分享 收藏
分享 收藏
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia Boyiadzis, Michael; Desai, Pinkal; Daskalakis, Nikki; Donnellan, William; Ferrante, Lucille; Goldberg, Jenna D.; Grunwald, Michael R.; Guttke, Christina; Li, Xiang; Perez-Simon, Jose Antonio; Salamero, Olga; Tucker, Trevor; Xu, Xiaoying; Yang, Jay; Pemmaraju, Naveen; Alonso-Dominguez, Juan Manuel 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
